These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8111805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T, Kohno Y, Koishi K.
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [Abstract] [Full Text] [Related]

  • 3. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H.
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
    Wakui K, Takemae T, Kobayashi S.
    No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Deguchi K, Shiku H.
    Pol J Pharmacol; 1996 Jul; 48(2):225-8. PubMed ID: 9112656
    [Abstract] [Full Text] [Related]

  • 6. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
    Wada H, Sakuragawa N, Shiku H.
    Semin Thromb Hemost; 1998 Jul; 24(3):293-7. PubMed ID: 9701463
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
    Minakata D, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Ohmori T, Kanda Y.
    Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
    Satokawa H, Iwaya F, Igari T, Abe T, Hagiwara K, Tanji M, Watanabe M, Midorikawa H, Sato Y, Takase S.
    Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
    [Abstract] [Full Text] [Related]

  • 14. Disseminated intravascular coagulation after hepatic resection.
    Tsuzuki T, Toyama K, Nakayasu K, Iida S, Ueda M, Toizumi A.
    Surgery; 1990 Feb; 107(2):172-6. PubMed ID: 2154054
    [Abstract] [Full Text] [Related]

  • 15. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T, Nakamura S, Imamura Y, Yoshioka S, Miyazaki T, Izumikawa K, Sawai T, Matsuo N, Yanagihara K, Suyama N, Kohno S.
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?
    Nishiyama T, Matsukawa T, Hanaoka K.
    Crit Care Med; 2000 May; 28(5):1419-22. PubMed ID: 10834689
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
    Isobe J.
    Adv Exp Med Biol; 1979 May; 120B():385-94. PubMed ID: 229708
    [Abstract] [Full Text] [Related]

  • 20. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
    Taenaka N, Shimada Y, Hirata T, Nishijima MK, Takezawa J, Yoshiya I, Kambayashi J.
    Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.